Appl Clin Inform 2017; 08(02): 541-559
DOI: 10.4338/ACI-2016-12-RA-0203
Research Article
Schattauer GmbH

Improving Medication Adherence with Two-way Short Message Service Reminders in Sickle Cell Disease and Asthma

A feasibility randomized controlled trial
Brandi M. Pernell
1   Vanderbilt-Meharry-Matthew Walker Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville TN
2   University of Alabama at Birmingham, Department of Pediatrics, Division of Hematology, Birmingham, AL
,
Michael R. DeBaun
1   Vanderbilt-Meharry-Matthew Walker Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville TN
,
Kathleen Becker
3   Johns Hopkins University, School of Nursing, Baltimore, MD
,
Mark Rodeghier
4   Rodeghier Consultants, Chicago, IL
,
Valencia Bryant
1   Vanderbilt-Meharry-Matthew Walker Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical Center, Nashville TN
,
Robert M. Cronin
5   Vanderbilt University Medical Center, Departments of Biomedical Informatics, Internal Medicine, and Pediatrics, Nashville, TN
› Author Affiliations
Funding This work was supported by the Junior League of Nashville, HRSA grant number 5-U38-MC2222–0–04–00, and the Trans-Institutional Programs at Vanderbilt University Medical Center.
Further Information

Publication History

received: 04 December 2016

accepted: 08 March 2017

Publication Date:
21 December 2017 (online)

Summary

Introduction: Sickle cell disease (SCD) is a childhood and adult disease that primarily affects African Americans, characterized by life threatening sequelae mitigated by medications. One-way and two-way short message service (SMS) medication reminders have differing efficacy in chronic diseases. There is limited literature about SMS medication reminders in SCD.

Objective: The goal of this study was to test the feasibility, defined by recruitment/acceptance, retention/attrition, and technology utilization, of two-way SMS medication reminders in individuals with SCD with and without asthma.

Materials and Methods: Participants were randomly allocated to standard care or reminders. Two-way SMS reminders were automated using Research Electronic Data Capture (REDCap) for hydroxyurea, fluticasone, budesonide and montelukast. Adherence was measured using the Morisky Medication Adherence Scale-8 (MMAS-8). Asthma control was assessed using the Childhood and Adult-Asthma Control Tests (ACT). Participants were enrolled 28 to 60 days with a common termination date.

Results: The recruitment rate was 95% (47/49) and 82.9% completed the study. Among the 47 study participants enrolled, 51.1% were male, 61.7% were adults, median age was 20 (range: 3 to 59), and 98% were African Americans. Of the 26 participants receiving messages, 20% responded on over 95% of the days and usage varied with an average response rate of 33%, ranging from 21% to 46%. Medication adherence scores improved significantly in the intervention group (3.42 before, 5.46 after; p=0.002), but not in the control group (3.90 before, 4.75 after; p=0.080). Childhood-ACT scores improved in the intervention group (19.20 before, 24.25 after). Adult-ACT scores within the intervention arm were unchanged (21.0 before, 22.0 after. ACT scores did not improve significantly.

Conclusion: This study demonstrated the feasibility for two-way SMS medication reminders to improve medication adherence in a high-risk population where daily medication adherence is critical to health outcomes and quality of life.

Citation: Pernell BM, DeBaun MR, Becker K, Rodeghier M, Bryant V, Cronin RM. Improving medication adherence with two-way short message service reminders in sickle cell disease and asthma: A feasibility randomized controlled trial. Appl Clin Inform 2017; 8: 541–559 https://doi.org/10.4338/ACI-2016-12-RA-0203

Human Subjects Protection

This study was approved by the Vanderbilt University Medical Center Institutional Review Board


 
  • References

  • 1 Prevention CfDCa. Data & Statistics 2015 [cited 2015 December 10]. Available from: http://www.cdc.gov/ncbddd/sicklecell/data.html
  • 2 Fox S. Health Topics: @pewinternet. 2011 [cited 2015 6/14/2015]. Available from: http://www.pewinternet.org/2011/02/01/health-topics-2/
  • 3 Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res 2015; 17 (02) e52. doi: 10.2196/jmir.3951. PubMed PMID: 25803266; PubMed Central PMCID: PMCPMC4376208.
  • 4 Jhamb M, Cavanaugh KL, Bian A, Chen G, Ikizler TA, Unruh ML, Abdel-Kader K. Disparities in electronic health record patient portal use in nephrology clinics. Clinical Journal of the American Society of Nephrology 2015; 10 (11) 2013-2022.
  • 5 Osborn CY, Mayberry LS, Wallston KA, Johnson KB, Elasy TA. Understanding patient portal use: implications for medication management. J Med Internet Res 2013; 15 (07) e133. doi: 10.2196/jmir.2589. PubMed PMID: 23823974; PubMed Central PMCID: PMCPMC3713921.
  • 6 Smith SG, O’Conor R, Aitken W, Curtis LM, Wolf MS, Goel MS. Disparities in registration and use of an online patient portal among older adults: findings from the LitCog cohort. J Am Med Inform Assoc 2015; 22 (04) 888-895. doi: 10.1093/jamia/ocv025. PubMed PMID: 25914099; PubMed Central PMCID: PMCPMC4810779.
  • 7 Nelson LA, Mulvaney SA, Gebretsadik T, Ho YX, Johnson KB, Osborn CY. Disparities in the use of a mHealth medication adherence promotion intervention for low-income adults with type 2 diabetes. J Am Med Inform Assoc 2016; 23 (01) 12-18. doi: 10.1093/jamia/ocv082. PubMed PMID: 26186935; PubMed Central PMCID: PMCPMC5009937.
  • 8 Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995; 332 (20) 1317-1322. doi: 10.1056/NEJM199505183322001. PubMed PMID: 7715639.
  • 9 Kinney TR, Helms RW, O’Branski EE, Ohene-Frempong K, Wang W, Daeschner C, Vichinsky E, ReddingLallinger R, Gee B, Platt OS, Ware RE. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999; 94 (05) 1550-1554. PubMed PMID: 10477679.
  • 10 Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW. investigators BH. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 2011; 377 9778 1663-1672. doi: 10.1016/S0140–6736(11)60355–3. PubMed PMID: 21571150; PubMed Central PMCID: PMCPMC3133619.
  • 11 Anim SO, Strunk RC, DeBaun MR. Asthma morbidity and treatment in children with sickle cell disease. Expert Rev Respir Med. 2011; 5 (05) 635-45. doi: 10.1586/ers.11.64. PubMed PMID: 21955234; PubMed Central PMCID: PMCPMC3233260.
  • 12 Newaskar M, Hardy KA, Morris CR. Asthma in sickle cell disease. Scientific World Journal 2011; 11: 1138-1152. doi: 10.1100/tsw.2011.105. PubMed PMID: 21623460.
  • 13 National Asthma E, Prevention P. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol 2007; 120 (05) S94-S138. doi: 10.1016/j.jaci.2007.09.043. PubMed PMID: 17983880.
  • 14 Candrilli SD, O’Brien SH, Ware RE, Nahata MC, Seiber EE, Balkrishnan R. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease. Am J Hematol 2011; 86 (03) 273-277. doi: 10.1002/ajh.21968. PubMed PMID: 21328441.
  • 15 DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42 (03) 200-209. PubMed PMID: 15076819.
  • 16 Thornburg CD, Calatroni A, Telen M, Kemper AR. Adherence to hydroxyurea therapy in children with sickle cell anemia. J Pediatr 2010; 156 (03) 415-419. doi: 10.1016/j.jpeds.2009.09.044. PubMed PMID: 19880135; PubMed Central PMCID: PMCPMC3901082.
  • 17 Walsh KE, Cutrona SL, Kavanagh PL, Crosby LE, Malone C, Lobner K, Bundy DG. Medication adherence among pediatric patients with sickle cell disease: a systematic review. Pediatrics 2014; 134 (06) 1175-1183. doi: 10.1542/peds.2014–0177. PubMed PMID: 25404717; PubMed Central PMCID: PMCPMC4243064.
  • 18 Badawy SM, Thompson AA, Lai JS, Penedo FJ, Rychlik K, Liem RI. Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease. Pediatr Blood Cancer. 2016 doi: 10.1002/pbc.26369. PubMed PMID: 27896936.
  • 19 Johnson KB, Patterson BL, Ho YX, Chen Q, Nian H, Davison CL, Slagle J, Mulvaney SA. The feasibility of text reminders to improve medication adherence in adolescents with asthma. J Am Med Inform Assoc. 2015 doi: 10.1093/jamia/ocv158. PubMed PMID: 26661717.
  • 20 Jhamb M, Cavanaugh KL, Bian A, Chen G, Ikizler TA, Unruh ML, Abdel-Kader K. Disparities in Electronic Health Record Patient Portal Use in Nephrology Clinics. Clin J Am Soc Nephrol 2015; 10 (11) 2013-2022. doi: 10.2215/CJN.01640215. PubMed PMID: 26493242; PubMed Central PMCID: PMCPMC4633780.
  • 21 Anderson C, Torres S, Gokuli S, Brandow AM, Panepinto JA. Assessment of communication modes in patients and families with sickle cell disease. Pediatr Blood Cancer 2013; 60 (05) 887. doi: 10.1002/pbc.24477. PubMed PMID: 23450782.
  • 22 Badawy SM, Thompson AA, Liem RI. Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease. Pediatr Blood Cancer. 2016 Epub 2016/02/05. doi: 10.1002/pbc.25905. PubMed PMID: 26844685.
  • 23 Lenhart A. Teens, social media & technology overview 2015. Pew Research Center; 2015: 9.
  • 24 Smith A. US smartphone use in 2015. Pew Research Center; 2015: 1.
  • 25 Thakkar J, Kurup R, Laba TL, Santo K, Thiagalingam A, Rodgers A, Woodward M, Redfern J, Chow CK. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. JAMA Intern Med 2016; 176 (03) 340-349. doi: 10.1001/jamainternmed.2015.7667. PubMed PMID: 26831740.
  • 26 Estepp JH, Winter B, Johnson M, Smeltzer MP, Howard SC, Hankins JS. Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia. Pediatr Blood Cancer 2014; 61 (11) 2031-2036. Epub 2014/08/19. doi: 10.1002/pbc.25177. PubMed PMID: 25132074.
  • 27 Wald DS, Butt S, Bestwick JP. One-way versus two-way text messaging on improving medication adherence: meta-analysis of randomized trials. Am J Med 2015; 128 (10) 1139 e1–5. doi: 10.1016/j.amjmed.2015.05.035 PubMed PMID: 26087045.
  • 28 QuickCalcs GS. Randomly assign subjects to treatment groups 2016 [cited 2016]. Available from: http://www.graphpad.com/quickcalcs/randomize1.cfm
  • 29 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381. doi: 10.1016/j.jbi.2008.08.010. PubMed PMID: 18929686; PubMed Central PMCID: PMCPMC2700030.
  • 30 Tickle-Degnen L. Nuts and bolts of conducting feasibility studies. The American journal of occupational therapy : official publication of the American Occupational Therapy Association 2013; 67 (02) 171-176. doi: 10.5014/ajot.2013.006270. PubMed PMID: 23433271; PubMed Central PMCID: PMCPMC3722658.
  • 31 Morisky DE, Ang A, Krousel Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. The Journal of Clinical Hypertension 2008; 10 (05) 348-354.
  • 32 Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 2009; 15 (01) 59-66. Epub 2009/01/17. PubMed PMID: 19146365; PubMed Central PMCID: PMCPMC2728593.
  • 33 Trindade AJ, Ehrlich A, Kornbluth A, Ullman TA. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis 2011; 17 (02) 599-604. doi: 10.1002/ibd.21310. PubMed PMID: 20848512.
  • 34 Schatz M, Sorkness CA, Li JT, Marcus P, Murray JJ, Nathan RA, Kosinski M, Pendergraft TB, Jhingran P. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 2006; 117 (03) 549-556. doi: 10.1016/j.jaci.2006.01.011. PubMed PMID: 16522452.
  • 35 Voorend-van Bergen S, Vaessen-Verberne AA, Landstra AM, Brackel HJ, van den Berg NJ, Caudri D, de Jongste JC, Merkus PJ, Pijnenburg MW. Monitoring childhood asthma: web-based diaries and the asthma control test. J Allergy Clin Immunol 2014; 133 (06) 1599-1605 e2. doi: 10.1016/j.jaci.2013.10.005. PubMed PMID: 24290276.
  • 36 Schatz M, Kosinski M, Yarlas AS, Hanlon J, Watson ME, Jhingran P. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol 2009; 124 (04) 719-723 e1. doi: 10.1016/j.jaci.2009.06.053. PubMed PMID: 19767070.
  • 37 Zeiger RS, Mellon M, Chipps B, Murphy KR, Schatz M, Kosinski M, Lampl K, Ramachandran S. Test for Respiratory and Asthma Control in Kids (TRACK): clinically meaningful changes in score. J Allergy Clin Immunol 2011; 128 (05) 983-988. doi: 10.1016/j.jaci.2011.08.010. PubMed PMID: 21906790.
  • 38 Hardy H, Kumar V, Doros G, Farmer E, Drainoni ML, Rybin D, Myung D, Jackson J, Backman E, Stanic A, Skolnik PR. Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS 2011; 25 (03) 153-161. doi: 10.1089/apc.2010.0006. PubMed PMID: 21323532; PubMed Central PMCID: PMCPMC3101947.
  • 39 Park LG, Howie-Esquivel J, Chung ML, Dracup K. A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Educ Couns 2014; 94 (02) 261-268. doi: 10.1016/j.pec.2013.10.027. PubMed PMID: 24321403.
  • 40 Wald DS, Bestwick JP, Raiman L, Brendell R, Wald NJ. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial). PLoS ONE 2014; 9 (12) e114268. doi: 10.1371/journal.pone.0114268. PubMed PMID: 25479285; PubMed Central PMCID: PMCPMC4257733.
  • 41 Lv Y, Zhao H, Liang Z, Dong H, Liu L, Zhang D, Cai S. A mobile phone short message service improves perceived control of asthma: a randomized controlled trial. Telemed J E Health 2012; 18 (06) 420-426. doi: 10.1089/tmj.2011.0218. PubMed PMID: 22667695.
  • 42 Strandbygaard U, Thomsen SF, Backer V. A daily SMS reminder increases adherence to asthma treatment: a three-month follow-up study. Respir Med 2010; 104 (02) 166-171. doi: 10.1016/j.rmed.2009.10.003. PubMed PMID: 19854632.
  • 43 Kannisto KA, Koivunen MH, Valimaki MA. Use of mobile phone text message reminders in health care services: a narrative literature review. J Med Internet Res 2014; 16 (10) e222. doi: 10.2196/jmir.3442. PubMed PMID: 25326646; PubMed Central PMCID: PMCPMC4211035.
  • 44 da Costa TM, Salomao PL, Martha AS, Pisa IT, Sigulem D. The impact of short message service text messages sent as appointment reminders to patients’ cell phones at outpatient clinics in Sao Paulo, Brazil. Int J Med Inform 2010; 79 (01) 65-70. doi: 10.1016/j.ijmedinf.2009.09.001. PubMed PMID: 19783204.
  • 45 Leong KC, Chen WS, Leong KW, Mastura I, Mimi O, Sheikh MA, Zailinawati AH, Ng CJ, Phua KL, Teng CL. The use of text messaging to improve attendance in primary care: a randomized controlled trial. Fam Pract 2006; 23 (06) 699-705. doi: 10.1093/fampra/cml044. PubMed PMID: 16916871.
  • 46 Wang K, Wang C, Xi L, Zhang Y, Ouyang Y, Lou H, Zhang W, Zhang L. A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message service (SMS) via the mobile phone. Int Arch Allergy Immunol 2014; 163 (01) 51-58. doi: 10.1159/000356317. PubMed PMID: 24248037.